Steven Ryder's most recent trade in MBX Biosciences Inc. was a trade of 16,000 Stock option (right to buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MBX Biosciences Inc. | Steven Ryder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 16,000 | 16,000 | - | - | Stock option (right to buy) | |
| Rallybio Corp | Steven Ryder | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 180,000 | 180,000 | - | - | Option (Right to Buy) | |
| MBX Biosciences Inc. | Steven Ryder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 15,963 | 15,963 | - | - | Stock Option (Right to Buy) | |
| Rallybio Corp | Steven Ryder | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 120,000 | 120,000 | - | - | Option (Right to Buy) | |
| Reata Pharmaceuticals Inc ... | Steven Ryder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 2,137 | 2,137 | - | - | Stock Option (right-to-buy) | |
| Reata Pharmaceuticals Inc ... | Steven Ryder | Director | Grant, award, or other acquisition of securities at price $ 93.61 per share. | 07 Jun 2023 | 1,682 | 10,907 (0%) | 0% | 93.6 | 157,452 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Steven Ryder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 441 | 441 | - | - | Stock Option (right-to-buy) | |
| Reata Pharmaceuticals Inc ... | Steven Ryder | Director | Grant, award, or other acquisition of securities at price $ 93.61 per share. | 07 Jun 2023 | 347 | 9,225 (0%) | 0% | 93.6 | 32,483 | Class A common stock |
| Rallybio Corp | Steven Ryder | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 119,000 | 119,000 | - | - | Option (Right to Buy) | |
| Rallybio Corp | Steven Ryder | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 62,000 | 62,000 | - | - | Option (Right to Buy) |